Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: A double-blind study

Journal of the American College of Cardiology

Volumn 36, Issue 2, 2000, Pages 410-416

  Mullen, Michael J ^a   Wright, David ^b   Donald, Ann E ^a   Thorne, Sara ^a   Thomson, Hyeyoung ^a   Deanfield, John E ^a  

^a HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ATORVASTATIN; GLYCERYL TRINITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADULT; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ADOLESCENT; ADULT; ARGININE; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PYRROLES; VASODILATION;

EID: 0033862040     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00743-9     Document Type: Article

References (50)

1. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus
2. Endothelium-dependent relaxation in aorta of BB rat
3. Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia
4. Flow-induced dilatation in isolated resistance arteries from control and streptozotocin-diabetic rats
5. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes
6. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus
7. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: Blunted vasoconstriction in patients with microalbuminuria
8. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolaemic young adults
9. Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria
10. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus
11. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus
12. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
13. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo
14. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
15. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo
16. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
17. Advanced glycosylation endproducts quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
18. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus
19. Susceptibility to oxidation and physicochemical properties of LDL in insulin-dependent diabetes
20. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase
21. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins
22. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation
23. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels
24. Binding and modification of proteins by methylglyoxal under physiological conditions
25. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat
26. The effect of high glucose on polyol pathway activity and myo-inositol metabolism in cultured human endothelial cells
27. Interactions between L-arginine and L-glutamine change endothelial NO production: An effect independent of NO synthase substrate availability
28. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury
29. Atherosclerosis and the two faces of endothelial nitric oxide synthase
30. Restoration of vascular endothelial function in diabetes
31. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium
32. Regression or progression: Dependency on vascular nitric oxide
33. Early endothelial dysfunction in adults at risk from atherosclerosis: Different responses to L-arginine
34. Randomized double blind placebo controlled study of supplemental oral L-arginine in patients with heart failure
35. Kinetics of HbA(1c), glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level
36. Estimation of the concentration of LDL-cholesterol in plasma without use of a preparative centrifuge
37. Non-invasive measurement of human endothelium dependent arterial response: Accuracy and reproducibility
38. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
39. Close relation of endothelial function in the human coronary and peripheral circulations
40. Diabetes and cardiovascular risk factors: The Framingham study
41. Cholesterol lowering with simvastatin improves the prognosis of diabetic patients with coronary heart disease
42. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
43. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
44. Statins do more than just lower cholesterol
45. Vascular and hormonal responses to arginine: Provision of substrate for nitric oxide or non-specific effect?
46. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits
47. The vascular effects of L-arginine in humans: The role of endogenous insulin
48. Arginine: A new therapy for atherosclerosis?
49. The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial